SSDP Australia: How is the World Health Organisation facilitating meaningful inclusion of people who use drugs in the design and implementation of policies and strategies around existing and emerging pharmacotherapies at the global level? WHO: The principle of involving affected groups in the development of guidance is strong. To develop WHO guidelines on managing health …
By Juan Fernandez
Side event: Exploring responsible legal regulation to promote human rights, health, and security in Europe
Organized by Foreningen for Human Narkotikapolitikk with the support of Czechia, Germany, the Office of the High Commissioner for Human Rights, Amnesty International, the International Drug Policy Consortium and the International Network of People who Use Drugs Marie Nougier, IDPC: IDPC is a global network of NOGs that promote drug policies that advance social justice …
Item 5. Implementation of the international drug control treaties (Tuesday morning)
Chair: We will consider scheduling recommendations by WHO and INCB. CND Secretariat: Recalls the substances and scheduling recommendations. Chair: Explains process to schedule substances under 1961, 1971 and 1988 conventions. Butonitazene WHO: Butonitazene, or butoxynitazene, is a benzimidazole-derived synthetic opioid not currently under international control and lacking recognized therapeutic use. It appears as a crystalline …
Item 5. Implementation of the international drug control treaties (Monday afternoon)
(c) International Narcotics Control Board Colombia: (TBA) Pakistan: Pakistan acknowledges and appreciates the effective role and efforts of the INCB in the collection of data, in-depth analysis, and compilation of the comprehensive report. We believe that the INCB report for 2023 will provide assistance to member states in aligning their national priorities and responses to …
Side event: The new regulatory models of psychoactive substances in the grey zone – A new challenge or an opportunity?
Organized by Czechia with the support of Canada, Colombia, Mexico, Switzerland, the United States, the International Drug Policy Consortium and the Transnational Institute Jindrich Voboril – Czech Republic: Why is Czechia organising this event? The Czech Republic is a country with only 10,000,000 people in Central Europe, in the centre of the European Union. We …
Item 3. High-level segment (Friday evening)
India: India acknowledges the challenges and affirms its commitment to fight the global drug menace. Our diversity and federal structure recognises that drug control requires a multi-agency coordination. India has a strong commitment to the guiding principles of the three drug control conventions, the ECOSOC and the General Assembly. We maintain a zero tolerance policy …